Polycystic Ovary Syndrome: Comprehensive Overview

    July 2018 in “ Obstetrics & Gynecology ”
    Ricardo Azziz
    Image of study
    TLDR PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.
    The document from August 1, 2018, provides a comprehensive overview of Polycystic Ovary Syndrome (PCOS), a common endocrine-metabolic disorder in reproductive-aged women with a prevalence of 5-20%. It describes PCOS as a complex polygenic, multifactorial disorder with increased risks for conditions like glucose intolerance, type 2 diabetes, metabolic syndrome, cardiovascular events, subfertility, and mood disorders. The diagnosis of PCOS involves confirming hyperandrogenism and oligo-anovulation through history, physical examination, hormonal testing, and ovarian ultrasonography, while excluding other disorders. Treatment is tailored to the patient's phenotype and goals, including suppressing androgen secretion and action, improving metabolic status, and enhancing fertility. The document also discusses the clinical presentation of PCOS, which can include hirsutism, acne, and alopecia, and the need for better education and vigilance among clinicians. It touches on the genetics and evolutionary aspects of PCOS, its pathophysiology involving insulin resistance and hyperinsulinemia, and the importance of screening for metabolic comorbidities. Therapeutic strategies include the use of combination oral contraceptives, antiandrogens, metformin, and fertility treatments. The document does not provide specific numbers from studies to assess the strength of the evidence.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 97 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 10 months ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    2 / 2 results